Stock listing
BOATS:JUNS Jupiter Neurosciences, Inc. Stock
US listing (BOATS) of Jupiter Neurosciences, Inc. · home listing NASDAQ:JUNS
Follow Jupiter Neurosciences, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:JUNS
$2.43 USD +0.12 (+5.2%)
Close on Nov 3, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:JUNS
- Day range
- $2.27 – $2.47 USDNov 3, 2026
- Volume
- 7,415 sharesNov 3, 2026
- Market cap
- $3.20M USDAt the close on Nov 3, 2026 · price × 1.32M shares outstanding
- 52-week range
- $2.05 – $103.50 USDLowest and highest trades, Nov 4, 2025 – Nov 3, 2026
- Traded on an average day
- $5.25M USDMedian day 35,500 shares · last 3 months, Aug 3, 2026 – Nov 3, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:JUNS · Home | $2.43 USD | +0.12 (+5.2%) | 7,415 | $2.37 | $2.47 | $2.27 | $2.31 | Close on Nov 3, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 3, 2026 · NASDAQ:JUNS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.43 | +0.12 | +5.2% | $2.37 | $2.47 | $2.27 | 7,415 | |
| $2.31 | +0.26 | +12.7% | $2.11 | $2.43 | $2.10 | 31,644 | |
| $2.05 | -0.32 | -13.5% | $2.40 | $2.41 | $2.05 | 17,256 | |
| $2.37 | -0.13 | -5.2% | $2.56 | $2.56 | $2.36 | 7,172 | |
| $2.50 | -0.14 | -5.3% | $2.62 | $2.70 | $2.40 | 29,722 | |
| $2.64 | -0.22 | -7.7% | $2.86 | $2.91 | $2.64 | 41,541 | |
| $2.86 | -0.12 | -4.0% | $3.00 | $3.01 | $2.717 | 12,669 | |
| $2.98 | +0.40 | +15.5% | $2.58 | $3.09 | $2.58 | 19,625 | |
| $2.58 | -0.20 | -7.2% | $2.76 | $2.76 | $2.551 | 10,140 | |
| $2.78 | -0.02 | -0.7% | $2.75 | $2.80 | $2.631 | 28,572 | |
| $2.80 | +0.05 | +1.8% | $2.75 | $3.24 | $2.75 | 10,408 | |
| $2.75 | -0.155 | -5.3% | $2.77 | $2.82 | $2.75 | 8,488 | |
| $2.905 | -0.235 | -7.5% | $3.09 | $3.115 | $2.881 | 13,924 | |
| $3.14 | -0.05 | -1.6% | $3.16 | $3.27 | $3.025 | 19,811 | |
| $3.19 | -0.17 | -5.1% | $3.30 | $3.43 | $3.07 | 20,925 | |
| $3.36 | +0.32 | +10.5% | $3.00 | $3.50 | $3.00 | 71,300 | |
| $3.04 | +0.19 | +6.7% | $2.89 | $3.04 | $2.76 | 37,200 | |
| $2.85 | +0.08 | +2.9% | $2.83 | $2.89 | $2.67 | 7,000 | |
| $2.77 | -0.07 | -2.5% | $2.70 | $2.85 | $2.66 | 36,800 | |
| $2.84 | -0.02 | -0.7% | $2.61 | $2.858 | $2.58 | 47,100 | |
| $2.86 | +0.44 | +18.2% | $2.38 | $3.18 | $2.251 | 924,100 | |
| $2.42 | -0.13 | -5.1% | $2.425 | $2.55 | $2.33 | 14,900 | |
| $2.55 | +0.05 | +2.0% | $2.50 | $2.60 | $2.50 | 11,600 | |
| $2.50 | +0.06 | +2.5% | $2.57 | $2.57 | $2.39 | 13,300 | |
| $2.44 | -0.14 | -5.4% | $2.51 | $2.61 | $2.35 | 16,800 | |
| $2.58 | +0.07 | +2.8% | $2.54 | $2.60 | $2.38 | 14,900 | |
| $2.51 | -0.16 | -6.0% | $2.67 | $2.67 | $2.40 | 53,000 | |
| $2.67 | -0.215 | -7.5% | $2.82 | $2.966 | $2.67 | 58,900 | |
| $2.885 | -0.085 | -2.9% | $3.06 | $3.06 | $2.80 | 36,800 | |
| $2.97 | -0.01 | -0.3% | $2.97 | $3.00 | $2.902 | 37,200 | |
| $2.98 | +0.11 | +3.8% | $2.90 | $3.68 | $2.86 | 455,700 | |
| $2.87 | +0.01 | +0.3% | $2.956 | $2.965 | $2.86 | 17,100 | |
| $2.86 | -0.15 | -5.0% | $3.05 | $3.14 | $2.86 | 17,600 | |
| $3.01 | +0.08 | +2.7% | $2.97 | $3.06 | $2.96 | 10,900 | |
| $2.93 | -0.08 | -2.7% | $3.02 | $3.19 | $2.88 | 22,000 | |
| $3.01 | -0.40 | -11.7% | $3.45 | $3.45 | $3.00 | 57,800 | |
| $3.41 | +0.36 | +11.8% | $3.12 | $3.557 | $3.06 | 73,000 | |
| $3.05 | -0.10 | -3.2% | $3.17 | $3.20 | $3.00 | 21,000 | |
| $3.15 | +0.06 | +1.9% | $3.05 | $3.406 | $3.05 | 41,700 | |
| $3.09 | +0.01 | +0.3% | $3.06 | $3.238 | $2.94 | 29,500 | |
| $3.08 | -0.20 | -6.1% | $3.20 | $3.28 | $3.06 | 41,000 | |
| $3.28 | +0.02 | +0.6% | $3.36 | $3.609 | $3.27 | 25,000 | |
| $3.26 | -0.17 | -5.0% | $3.46 | $3.49 | $3.26 | 20,600 | |
| $3.43 | +0.08 | +2.4% | $3.35 | $3.52 | $3.27 | 35,000 | |
| $3.35 | -0.19 | -5.4% | $3.39 | $3.57 | $3.22 | 59,200 | |
| $3.54 | -0.64 | -15.3% | $3.00 | $3.65 | $2.88 | 258,200 | |
| $4.18 | -0.71 | -14.5% | $5.15 | $5.15 | $4.101 | 254,800 | |
| $4.89 | -0.12 | -2.4% | $4.94 | $5.00 | $4.711 | 86,800 | |
| $5.01 | -0.16 | -3.1% | $4.67 | $5.40 | $4.621 | 222,700 | |
| $5.17 | -0.49 | -8.7% | $5.58 | $5.692 | $4.93 | 228,518 | |
| $5.66 | -0.54 | -8.7% | $5.65 | $6.00 | $5.42 | 632,861 | |
| $6.20 | +1.03 | +19.9% | $8.25 | $11.20 | $5.50 | 52,405,500 | |
| $5.17 | +0.37 | +7.7% | $4.80 | $5.23 | $4.80 | 36,000 | |
| $4.80 | -0.26 | -5.1% | $4.94 | $5.044 | $4.74 | 24,200 | |
| $5.06 | -0.12 | -2.3% | $4.98 | $5.18 | $4.80 | 29,600 | |
| $5.18 | -0.06 | -1.1% | $5.10 | $5.25 | $4.82 | 39,300 | |
| $5.24 | -0.76 | -12.7% | $5.86 | $6.06 | $5.01 | 106,000 | |
| $6.00 | +1.39 | +30.2% | $4.62 | $6.10 | $4.62 | 223,500 | |
| $4.61 | -0.09 | -1.9% | $4.60 | $4.98 | $4.56 | 25,200 | |
| $4.70 | -0.61 | -11.5% | $5.33 | $5.478 | $4.61 | 37,100 | |
| $5.31 | +0.21 | +4.1% | $5.31 | $5.77 | $5.27 | 39,600 | |
| $5.10 | -0.532 | -9.5% | $5.30 | $5.63 | $4.76 | 119,200 | |
| $5.632 | -0.143 | -2.5% | $5.917 | $5.917 | $5.40 | 21,073 | |
| $5.775 | -1.995 | -25.7% | $6.60 | $6.60 | $5.325 | 88,620 | |
| $7.77 | +0.27 | +3.6% | $7.275 | $8.25 | $7.275 | 42,082 | |
| $7.50 | +0.75 | +11.1% | $6.735 | $7.875 | $6.735 | 164,229 |
- Ticker
- BOATS:JUNS
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 6, 2026
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
Latest deck · Apr 2, 2026
Investor Presentation (April 2026)
Investor deck · 14 slides
Latest news
Jupiter Neurosciences Announces First Patient Dosed in Phase 2a RESET Trial in Parkinson’s Disease and Exploration of Strategic Options to Maximize Shareholder Value
Oct 6, 2026
Closed $2.86 (+18.2%) on Oct 6, 2026
Jupiter Neurosciences, Inc. Announces Reverse Stock Split
Aug 5, 2026
Closed $5.77 (-25.7%) on Aug 5, 2026
Jupiter Neurosciences Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
Jul 22, 2026
Closed $13.09 (+2.9%) on Jul 22, 2026
Jupiter Neurosciences Strengthens Board with Appointment of Dr. Tomas J. Philipson
Jul 7, 2026
Closed $16.19 (-2.4%) on Jul 7, 2026
Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a RESET Trial in Parkinson’s Disease
May 27, 2026
Closed $17.99 (+4.3%) on May 27, 2026
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq: JUNS) in Connection with its ~$2 Million Registered Direct Offering
May 26, 2026
Closed $17.25 (-3.3%) on May 26, 2026
Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering
May 21, 2026
Closed $20.31 (+32.1%) on May 21, 2026
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
May 20, 2026
Closed $15.37 (-35.9%) on May 20, 2026
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
May 20, 2026
Closed $15.37 (-35.9%) on May 20, 2026
Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit
May 4, 2026
Closed $30.23 (+3.3%) on May 4, 2026
Decks
Investor Presentation (April 2026)
Investor deck · 14 slides · Apr 2, 2026
Investor Presentation (2025)
Investor deck · 10 slides · Dec 9, 2025
Jupiter Neurosciences, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 42 in all · newest Oct 6, 2026 · oldest 2025
- Decks
- 2 decks · latest Apr 2, 2026
Where Jupiter Neurosciences, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:JUNS · Home listing | NASDAQ | United States | USD |
| BOATS:JUNS · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Jupiter Neurosciences, Inc.